Biochemistry

Biochemistry

Designing Protein-Based Nanoparticles for Therapeutic Applications: A New Frontier in Personalized Medicine

Recent research published in ACS Applied Materials & Interfaces has shed light on the design of protein-based nanoparticles for therapeutic applications, a promising area in personalized medicine. According to the study, protein-based nanoparticles (PNPs) have the potential to achieve precise control over drug loading, release kinetics, and targeting, making them

Biochemistry

Optimized Size Exclusion Chromatography Reveals Extracellular Vesicles as Key Carriers of ALK Translocations in Non-Small Cell Lung Cancer

Researchers at the Spanish National Centre for Biotechnology (CNB-CSIC) have made a groundbreaking discovery in the field of oncology by identifying extracellular vesicles (EVs) as the primary carriers of fusion RNA in non-small cell lung cancer (NSCLC) patients. This finding has significant implications for the diagnosis and treatment of NSCLC,

Biochemistry

Advances in Clonality Analysis of Human T-Cell Leukemia Virus Type 1-Infected Cells: A Breakthrough in Oncology Research

Researchers at Kumamoto University have made significant progress in understanding the human T-cell leukemia virus type 1 (HTLV-1) pathogenesis, a hematological malignancy with a poor prognosis. By employing high-throughput sequencing and advanced molecular techniques, the study has enabled the analysis of clonal dynamics and proviral structure in HTLV-1-infected cells. This

Biochemistry

Breakthrough in Squamous Cell Carcinoma Treatment: Anti-B7-H3 Nanobody and DM1 Conjugate Show Promising Results

Researchers at the University of Hong Kong-Shenzhen Hospital have made a significant breakthrough in the treatment of esophageal squamous cell carcinoma (ESCC), a highly aggressive malignancy with poor therapeutic outcomes. According to a recent study published in the International Journal of Biological Macromolecules, the team has developed a novel B7-H3-specific

Biochemistry

DACT3-DVL1 Interaction-Mediated Canonical WNT Signaling Regulates Non-Small Cell Lung Cancer Progression and Cisplatin Resistance

Researchers at China Medical University have made a significant discovery in understanding the mechanisms of non-small cell lung cancer (NSCLC) progression and cisplatin resistance. Their study, published in The FASEB Journal, reveals that the interaction between disheveled binding antagonist of b-catenin 3 (DACT3) and disheveled 1 (DVL1) inhibits the DVL1-induced